Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Stiolto respimat 2.5 2.5 mcg inh 4gm?

See the DrugPatentWatch profile for Stiolto

Stiolto Respimat® (umeclidinium bromide + vilanterol)
2.5 µg / 2.5 µg inhalation, 4 g cartridge (approx.)


1. What is Stiolto Respimat®?

Component Drug MOA Typical Use
Umeclidinium bromide Long‑acting muscarinic antagonist (LAMA) Blocks M3 receptors → bronchodilation, reduced airway resistance Maintenance bronchodilation in COPD
Vilanterol Long‑acting β2‑agonist (LABA) β2‑adrenergic agonist → smooth‑muscle relaxation Maintenance bronchodilation in COPD and asthma
  • Device: Respimat® soft‑mist inhaler – delivers a fine mist for efficient lung deposition.
  • Dose per puff: 2.5 µg umeclidinium + 2.5 µg vilanterol (≈ 5 µg total).
  • Cartridge weight: ~4 g (the “4 g” in the package refers to the total mass of the inhaler cartridge, not the drug dose).

2. Indications

Condition Patient group Frequency of use
COPD (emphysema, chronic bronchitis) Adults ≥18 y Twice daily (morning & evening)
Asthma (maintenance therapy) Adults & adolescents ≥12 y Twice daily

Note: It’s not a rescue inhaler. Use it only as prescribed for regular, long‑term control.


3. How to Use

  1. Shake the inhaler 10‑15 times before each use.
  2. Prime the device if it’s the first dose or hasn’t been used in >2 days (usually 2–3 puffs).
  3. Inhale slowly and deeply while pressing the inhaler.
  4. Hold breath for ~5 s (if possible) before exhaling.
  5. Repeat for the second puff.
  6. Rinse mouth after use (especially with LABAs) to reduce oral thrush risk.

Tip: Use a spacer only if you have difficulty coordinating inhalation with actuation; the Respimat is designed for direct inhalation, so a spacer isn’t typically needed.


4. Dosage

Condition Dose Frequency
COPD (maintenance) 2.5 µg / 2.5 µg twice daily Twice daily
Asthma (maintenance) 2.5 µg / 2.5 µg twice daily Twice daily

Adjustments:

  • CYP2D6 poor metabolizers: may have higher vilanterol exposure; monitor for bronchospasm or tremor.
  • Severe renal/hepatic impairment: not formally studied; use with caution.

5. Common Adverse Effects

Symptom Frequency How to manage
Dry mouth, throat irritation ~10–20 % Rinse mouth, drink water
Upper‑respiratory infections ~5–10 % Treat with antibiotics if bacterial
Tremor, palpitations ~5 % Consider dose reduction or switch to LAMA alone
Nasal congestion <5 % Decongestants (short‑term)
Increased intraocular pressure (rare) <1 % Ophthalmologic monitoring in glaucoma pts

Serious but rare: bronchospasm, paradoxical bronchoconstriction, chest pain, heart failure exacerbation.


6. Contraindications & Precautions

  • Contraindications:
    • Known hypersensitivity to umeclidinium, vilanterol, or any inhaler excipients.
    • Severe asthma attack or acute exacerbation (use rescue inhaler).
  • Precautions:
    • Cardiovascular disease: Vilanterol can increase heart rate & blood pressure; monitor.
    • Diabetes: β‑agonist can raise blood glucose; monitor HbA1c.
    • Pregnancy & lactation: Limited data; use only if benefits outweigh risks.
    • Pediatric (<12 y): Not approved for asthma in children <12 y; for COPD in younger adults, evidence is limited.

7. Drug Interactions

Drug Effect Management
β‑blockers (non‑selective) May blunt bronchodilation Use cardioselective β1‑blocker if necessary
CYP2D6 inhibitors (e.g., fluoxetine) ↑ Vilanterol plasma levels Monitor for β‑agonist toxicity; consider dose adjustment
MAO‑I inhibitors ↑ β‑agonist risk Avoid combination
Other bronchodilators (e.g., salmeterol) Additive effects Avoid duplication; adjust therapy accordingly

General rule: If starting a new drug that may affect β‑agonist activity, monitor for tachycardia, tremor, or palpitations.


8. Storage & Expiry

  • Temperature: Store below 30 °C (86 °F).
  • Humidity: Keep dry.
  • Expiry: Check the “best before” date on the cartridge. Do not use past expiry.

9. Misconceptions & FAQ

Question Answer
Is Stiolto a rescue inhaler? No. It’s a maintenance therapy. Use only as prescribed; for acute wheeze, use a short‑acting β2‑agonist.
Can I use it for asthma? Yes, as maintenance therapy for adults and adolescents ≥12 y, but not for acute attacks.
How many puffs per day? Two puffs twice daily (total four puffs/day).
Why is it called “4 g”? The inhaler cartridge weighs about 4 g; the drug dose per puff is only 5 µg total.
What if I miss a dose? Take the missed dose as soon as you remember. Skip if it’s close to the next scheduled dose.

10. When to Seek Medical Attention

  • Sudden worsening of breathing (dyspnea, wheeze).
  • Chest pain or palpitations.
  • Signs of severe allergic reaction: rash, itching, swelling, shortness of breath.
  • Persistent tremor or anxiety.

Bottom line

Stiolto Respimat® (2.5 µg / 2.5 µg) is a once‑daily inhaled combination of a LAMA and a LABA used for long‑term bronchodilation in COPD and asthma. Use it as prescribed, keep the cartridge dry and below 30 °C, and monitor for side effects, especially in patients with cardiovascular disease or on interacting medications. If you have any doubts about dosing, interactions, or side effects, always consult your healthcare provider.



Other Questions About Stiolto :

Stiolto clinical trial findings? Stiolto copd clinical trials efficacy? Stiolto clinical trials findings? What is comparable to stiolto? Stiolto respimat inhal spray? Is there a generic for stiolto respimat? Stiolto savings cards for copd treatment?